FDA Inspection 1218308 — Kentucky Blood Center Inc

Kentucky Blood Center Inc — FEI 1070402

The FDA completed an inspection of Kentucky Blood Center Inc on September 18, 2023 in Lexington, KY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 18, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Lexington, KY (United States)

Citations

IDCFRDescription
927121 CFR 610.41Donor Deferral - reentry